(Q53951145)

22 May 2018

title

Tumour necrosis factor-alpha plasma levels in elderly patients with Type 2 diabetes mellitus-observations over 2 years. (English)

1 reference

22 May 2018

0 references

0 references

Lechleitner M

1

1 reference

22 May 2018

Herold M

2

1 reference

22 May 2018

Dzien-Bischinger C

3

1 reference

22 May 2018

Hoppichler F

4

1 reference

22 May 2018

Dzien A

5

1 reference

22 May 2018

publication date

1 November 2002

1 reference

22 May 2018

published in

Diabetic Medicine

1 reference

22 May 2018

volume

19

1 reference

22 May 2018

issue

11

1 reference

22 May 2018

page(s)

949-953

1 reference

22 May 2018

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Pioglitazone time-dependently reduces tumour necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Increased expression of tumor necrosis factor-alpha in diabetic macrovasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Inhibition of tumor necrosis factor-alpha with anti-diabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Ageing, exercise and food restriction: effects on body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Pravastatin down-regulates inflammatory mediators in human monocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

Increased levels of C-reactive protein in noncontrolled type II diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00846.X

10.1046/J.1464-5491.2002.00846.X

21 January 2018

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

12421433

1 reference

22 May 2018